Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
Pierre-François MeyerNicholas James AshtonThomas K KarikariCherie Strikwerda-BrownTheresa KöbeJulie GonneaudAlexa Pichet BinetteHazal OzlenYara YakoubJoel SimrénJosef PanneeJuan Lantero-RodriguezAnne LabontéSuzanne L BakerMichael SchöllEugeen VanmechelenJohn C S BreitnerHenrik ZetterbergKaj BlennowJudes PoirierSylvia Villeneuvenull nullPublished in: Annals of neurology (2022)
biomarkers detected early AD pathology and cognitive decline. Such markers could be used as prescreening tools to reduce the cost of prevention trials. ANN NEUROL 2022;91:548-560.